Namita Kundu - Concepedia

Author

Namita Kundu

University of Maryland, Baltimore

Also Known As

Namita Kundu

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore U-M Rogel Cancer Center University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore VA Medical Center University of Maryland Medical Center

About

Namita Kundu is an author at University of Maryland, Baltimore specializing in medicine, cell biology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	17	1.3K
2	Health Sciences	2	2	99
3	Biochemistry	2	2	123
4	Natural Sciences	1	1	67
5	Allergy	1	1	48

Namita Kundu

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Antagonism of CXCR3 Inhibits Lung Metastasis in a Murine Model of Metastatic Breast Cancer Tonya C. Walser, Salah Rifat, Xinrong Ma, Cancer Research	2006	236
Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer. Namita Kundu, Amy M. Fulton PubMed Tumor BiologyBreast OncologySelective Cox-2 InhibitorChemoprevention StrategyCox-2 Inhibitors	2002	193
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4 Dawn Holt, Xinrong Ma, Namita Kundu, Cancer Immunology Immunotherapy InflammationCytokineProstaglandin E2Signal TransductionSignaling Pathway	2011	160
Prostaglandin E Receptor EP4 Antagonism Inhibits Breast Cancer Metastasis Xinrong Ma, Namita Kundu, Salah Rifat, Cancer Research	2006	159
CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model Xinrong Ma, Kelly J. Norsworthy, Namita Kundu, Molecular Cancer Therapeutics	2009	146
Interleukin-10 Inhibits Tumor Metastasis, Downregulates MHC Class I, and Enhances NK Lysis Namita Kundu, Amy M. Fulton Cellular Immunology Immune EvasionCancer ImmunosurveillanceDownregulates Mhc ClassImmunologyTumor Immunity	1997	139
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer Namita Kundu, Qingyuan Yang, Russell Dorsey, International Journal of Cancer	2001	116
A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE<sub>2</sub>-mediated immunosuppression and inhibits breast cancer metastasis Xinrong Ma, Dawn Holt, Namita Kundu, OncoImmunology	2013	99
Immune-mediated Modulation of Breast Cancer Growth and Metastasis by the Chemokine Mig (CXCL9) in a Murine Model Tonya C. Walser, Xinrong Ma, Namita Kundu, Journal of Immunotherapy Breast Cancer GrowthBreast OncologyImmunologyNk CellsImmunoediting	2007	86
Modulation of Host Natural Killer Cell Functions in Breast Cancer via Prostaglandin E2 Receptors EP2 and EP4 Dawn Holt, Xinrong Ma, Namita Kundu, Journal of Immunotherapy Pge2 ProductionBreast OncologyChemoprevention StrategyImmunologyImmune Regulation	2012	84

Page 1